TuesdaySep 03, 2024 12:24 pm

CBDNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Material Transfer Agreement to Evaluate DehydraTECH(TM) Technology in Pre-Clinical Setting

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has entered into a Materials Transfer Agreement with a pharmaceutical company. Under the terms of the agreement, the pharmaceutical company will evaluate Lexaria’s DehydraTECH(TM) technology in a pre-clinical setting. Lexaria will be responsible for formulating and supplying certain DehydraTECH compositions, with the pharmaceutical company evaluating the pharmacokinetics of these compositions in animal studies. According to the company, Lexaria has awarded the pharmaceutical company a temporary exclusive license option limited to specific DehydraTECH concepts and formulations under examination. The work is expected to be completed within roughly 6 months…

Continue Reading

FridayAug 30, 2024 2:45 pm

CBDNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) BayMedica Poised as Rare Cannabinoids Drive Market Growth

InMed Pharmaceuticals’ (NASDAQ: INM) subsidiary BayMedica is positioned amid a growing interest in edibles infused with non-intoxicating minor cannabinoids. These lesser-known cannabinoids offer unique properties and potential health benefits, driving significant market growth. The company published a report on the expansion of the minor cannabinoid market in 2023. “The report, based on data from Headset, the largest industry dataset, explores the growth, competition and consumer trends in ten regulated states, encompassing 85 million of the 158 million residents in areas where recreational cannabis is legal,” reads a recent article. “The report highlights a 5.4% revenue increase in the edible market,…

Continue Reading

FridayAug 30, 2024 1:45 pm

CBDNewsBreaks – Software Effective Solutions Corp. (SFWJ) Stakes Antioquia Valley to Begin Initial Production Rollout

With a focus on the global horizon, Software Effective Solutions (OTC: SFWJ) has a vision of building its partner companies into one of the world’s most advanced cannabinoid production and processing organizations. “MedCana has taken the first step in achieving that global mission. Recognizing that ideal climate conditions produce a better yield, the company announced that it has ‘searched the world over, and believes the Antioquia Valley, near Medellin [Colombia], is the perfect location to begin initial rollout of technology and production,” reads a recent article. “We are partnering with companies [in the valley] to begin implementation of our technology…

Continue Reading

FridayAug 30, 2024 1:20 pm

CBDNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Makes ‘Transformative Step’ in Vision to Build Diverse Portfolio

Golden Triangle Ventures (OTC: GTVH) previously announced a full-service freight brokerage business designed to significantly expand its logistics capabilities in a strategic move that aligns with its vision to assemble a strong portfolio. “The announcement comes as the company completed its acquisition of Cargo Management Group from T&K Zarro LLC and received the full financial commitment needed to launch the freight brokerage business. The Cargo Management Group acquisition includes a full-fledged logistics operation, brokerage business, licenses, and all associated assets… Golden Triangle Ventures also noted that, along with the acquisition, the company received full financial support from T&K Zarro to…

Continue Reading

ThursdayAug 29, 2024 12:12 pm

CBDNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Additional Tolerability, PK Test Results

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is reporting that the tolerability and additional pharmacokinetic (“PK”) results from its human pilot study #2, GLP-1-H24-2, have been received. According to the results, absorption improvements appear to continue with DehydraTECH-processed Rybelsus(R) vs. Rybelsus tablets, even under “fed” conditions. The results also show that DehydraTECH-treated Rybelsus does absorb through a mouth-melt product format. “We were pleased to find that none of the nine people taking the DehydraTECH-processed Rybelsus swallowed as a capsule experienced any adverse events whatsoever,” the company stated in the press release. “However, of the nine human…

Continue Reading

ThursdayAug 22, 2024 2:57 pm

CBDNewsBreaks – Software Effective Solutions Corp. (SFWJ) Poised for Success Amid Looming Changes in Cannabis Industry

Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana) is looking to become the world’s premier resource for pharmaceutical cannabis products. “With a significant majority of Americans supporting cannabis use and the U.S. government on the verge of changing the status of the substance under the Controlled Substances Act (‘CSA’), Software Effective Solutions is positioning itself for marked growth and success in the coming months,” a recent article reads. “With these looming changes as a backdrop, MedCana’s commitment to building the technology, laboratories, growing facilities and scientific teams needed to provide premium pharmaceutical-grade cannabis extracts to the world is perfectly timed. Committed…

Continue Reading

ThursdayAug 22, 2024 10:22 am

CBDNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Subsidiary Secures Motor Carrier Authority, DOT Licenses

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, today announced that its wholly owned subsidiary, LE Logistics, LLC (LE”), has officially secured the Motor Carrier Authority (“MC”) and U.S. Department of Transport (“DOT”) licenses. This development positions LE to immediately launch its freight division under the Golden Triangle Ventures umbrella and sets the stage for a stronger and more compliant operational foundation. In addition, it positions LE to start operations with its initial fleet of assets under a brand-new, clean operating license. The licenses also prime LE to execute its strategy of operating a larger fleet of assets, driving…

Continue Reading

WednesdayAug 21, 2024 12:39 pm

CBDNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Positive Interim Animal Study Results Supporting Potential Utility of DehydraTECH-CBD in Diabetes Control

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced receipt of blood glucose results from weeks 4 and 8 of its ongoing animal study WEIGHT-A24-1. The study is underway using diabetic, pre-conditioned Zucker rats. The results showed that DehydraTECH-liraglutide (Group H) and two DehydraTECH-CBD formulations (Groups A and B) were the top performers in the study at day 56, reducing blood sugar levels by 2.50%, 1.90% and 1.53% respectively. These results appear to support Lexaria’s belief that DehydraTECH-CBD may have utility, particularly if used together with a GLP-1 drug, in diabetic control. Additionally, select DehydraTECH-CBD…

Continue Reading

WednesdayAug 21, 2024 11:09 am

CBDNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Three U.S. Patent Issuances

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary small molecule drug candidates, today announced its receipt of three patents granted in the U.S., strengthening its patent portfolio. The issued patents include one for its formulation and method of use in the treatment of epidermolysis bullosa and related connective tissue disorders, one for biosynthesis manufacturing processes and one for an ocular drug delivery formulation. As of August 20, 2024, InMed has a total of 13 patent families covering new chemical entities, formulations, manufacturing processes and methods of use. “We are pleased to…

Continue Reading

ThursdayAug 15, 2024 11:41 am

CBDNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Reports on Voting Results of 2024 Annual and Special Meeting of Shareholders

Flora Growth (NASDAQ: FLGC), a consumer-packaged goods leader and pharmaceutical distributor, is reporting on its 2024 Annual and Special Meeting of Shareholders. The meeting. According to the announcement, shareholders voted on and approved all five proposals on the agenda. Proposals included the election of four directors to the company’s board of directors; the reappointment of Davidson & Company LLP, an independent registered public accounting firm, as the company auditors; amending FLGC’s Incentive Compensation Plan to increase the issuable number of shares; granting stock appreciation rights to the company's CEO and CFO; and issuing 635,363 shares in accordance with NASDAQ guidelines…

Continue Reading

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000